IMDX
Insight Molecular Diagnostics
IMDX
IMDX
30 hedge funds and large institutions have $48.9M invested in Insight Molecular Diagnostics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less capital invested
Capital invested by funds: $49.2M → $48.9M (-$322K)
2.88% less ownership
Funds ownership: 56.27% → 53.38% (-2.9%)
Holders
30
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$659K | |
| 2 | +$78.8K | |
| 3 | +$38.4K | |
| 4 |
BlackRock
New York
|
+$20.9K |
| 5 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$15.1K |
Top Sellers
| 1 | -$142M | |
| 2 | -$226K | |
| 3 | -$99.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$54K |
| 5 |
SG Americas Securities
New York
|
-$51K |
